Neurosense Therapeutics Ltd
NRSN
Detailliertes Diagramm anzeigen
0.940USD
+0.070+8.03%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
23.12MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+8.03%
5 Tage
+2.16%
1 Monat
+7.91%
6 Monate
-29.86%
Seit Jahresbeginn
+22.22%
1 Jahr
-20.48%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Kein Aktien-Score verfügbar aufgrund unzureichender Daten.
Neurosense Therapeutics Ltd Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Gesamteinnahmen
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Neurosense Therapeutics Ltd Informationen
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
BörsenkürzelNRSN
UnternehmenNeurosense Therapeutics Ltd
CEOBen-Noon (Alon)
Websitehttps://www.neurosense-tx.com/
Verwandte Finanzinstrumente
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%Beliebte Symbole
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69997.350
+27.220 (+0.04%)
282.580
+22.390 (+8.61%)
2078.500
+26.770 (+1.31%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
